Tampa International Airport executive resigns amid conflict of interest inquiry Agricultural research employee killed in wreck north of Brooksville Jon Gruden just what University of Miami needs in a coach Health Briefs: As weight soars, so does risk of death Tours available for electrophysiology lab at Hudson hospital HCA trauma plan reveals politics behind lifesaving service Flexible spending accounts to require prescriptions for over-the-counter drugs Briefs: Study finds that low-carb diet can help losers keep weight off Briefs: As weight soars, so does risk of death In Print: Thursday, December 2, 2010 Science & Technology
FDA okays stem cell study on eye patients
The Food and Drug Administration has approved a request by Advanced Cell Technology to inject cells created from human embryonic stem cells into the eyes of 12 patients suffering from advanced cases of Stargardt's macular dystrophy, which progressively destroys vision, usually beginning in childhood. It is currently incurable. The study will involve injecting 50,000 to 200,000 cells known as retinal pigment epithelial cells in the hopes that they will replace those ravaged by the disease. "I think this marks the beginning of a new era for stem cell research," said Robert Lanza, the company's chief scientific officer.